Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study

Calabro', L; Rossi, G; Morra, A; Di Giacomo, AM; Amato, G; Rosati, C; Cutaia, O; Daffina, MG; Giannarelli, D; Maio, M

JOURNAL OF THORACIC ONCOLOGY, 2019; 14 (10): S267